Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Colombiana de Cardiología
Print version ISSN 0120-5633
Abstract
DAVILA, Fabián et al. Hypertrophic cardiomyopathy: 5 year experience. Rev. Colomb. Cardiol. [online]. 2017, vol.24, n.3, pp.297-297. Epub Aug 12, 2016. ISSN 0120-5633. https://doi.org/10.1016/j.rccar.2016.06.004.
Introduction:
Hypertrophic cardiomyopathy is defined as the thickening of the left ventricular wall that is not explained by abnormal loading conditions, imposing a risk for arrhythmias, heart failure and sudden death. We attempt to identify the prevalence, clinical features and treatment of patients with hypertrophic cardiomyopathy assisted within our institution.
Material and methods:
Records of patients with hypertrophic cardiomyopathy were pulled and analysed, defining general features and exploring differences among subgroups; all statistical contrasts assumed a confidence of 95%.
Results:
22 cases of hypertrophic cardiomyopathy were assessed, 40.9% of whom were female, average age was 54. 77.27% showed mitral insufficiency, 63.4% reported chest pain, 68.18% were receiving renin inhibitor therapy and 95.45% were taking beta blockers. Average septum thickness was 22.77 mm, prevalence of atrial fibrillation was 22.7% and coronary disease 18%.
Conclusion:
Prevalence of hypertrophic cardiomyopathy during the 2009-2013 period was of 2.35%, mostly related to mitral insufficiency and previous history of chest pain; prevalence of atrial fibrillation in patients with hypertrophic cardiomyopathy in our study was of 22.7%,and 28% for coronary disease.
Keywords : Chest pain; Hypertrophic cardiomyopathy; Sudden cardiac death; Tachyarrhythmias; Atrial fibrillation.